JANUARY, 2004
Diagnosis, Diagnostics,
Immunodiagnosis & Immunodiagnostics:
8549.
Baker B, Evans M, DeCastro F, Schosser R. Leprosy in a Mexican immigrant.
J Ky Med Assoc. 2003 Jul;101(7):289-94.
8550.
Delobel P, Launois P, Djossou F, Sainte-Marie D, Pradinaud R. American
cutaneous leishmaniasis, lepromatous leprosy, and pulmonary tuberculosis
coinfection with downregulation of the T-helper 1 cell response. Clin Infect
Dis. 2003 Sep 1;37(5):628-33. Epub 2003 Aug 07.
8551.
Jardim MR, Antunes SL, Santos AR, Nascimento OJ, Nery JA, Sales AM,
Illarramendi X, Duppre N, Chimelli L, Sampaio EP, Sarno EP. Criteria for
diagnosis of pure neural leprosy. J Neurol. 2003 Jul;250(7):806-9.
8552.
Kang TJ, Kim SK, Lee SB, Chae GT, Kim JP. Comparison of two different PCR
amplification products (the 18-kDa protein gene vs. RLEP repetitive sequence) in
the diagnosis of Mycobacterium leprae. Clin Exp Dermatol. 2003 Jul;28(4):420-4.
Pathogenesis:
8553.
Bleharski JR, Li H, Meinken C, Graeber TG, Ochoa MT, Yamamura M, Burdick
A, Sarno EN, Wagner M, Rollinghoff M, Rea TH, Colonna M, Stenger S, Bloom BR,
Eisenberg D, Modlin RL. Use of
genetic profiling in leprosy to discriminate clinical forms of the disease.
Science. 2003 Sep 12;301(5639):1527-30.
8554.
Cemerski S, van Meerwijk JP, Romagnoli P. Oxidative-stress-induced T
lymphocyte hyporesponsiveness is caused by structural modification rather than
proteasomal degradation of crucial TCR signaling molecules. Eur J Immunol. 2003
Aug;33(8):2178-85.
8555.
Salem II, Steffan G, Duzgunes N. Efficacy of clofazimine-modified
cyclodextrin against Mycobacterium avium complex in human macrophages. Int J
Pharm. 2003 Jul 9;260(1):105-14.
Therapy:
8556.
Greenstein RJ. Is Crohn's disease caused by a mycobacterium? Comparisons
with leprosy, tuberculosis, and Johne's disease. Lancet Infect Dis. 2003
Aug;3(8):507-14. Review.
8557.
Perri AJ 3rd, Hsu S. A review of thalidomide's history and current
dermatological applications. Dermatol Online J. 2003 Aug;9(3):5. Review.
8558.
Sayal
SK; Das AL; Deora MS Trial of ofloxacin in paucibacillary leprosy Indian Journal of Dermatology. 2003
Jan-Mar; 48(1): 27-9.
APRIL, 2004
Diagnosis,
Diagnostics, Immunodiagnosis & Immunodiagnostics:
9214.
Erhabor GE, Adewole O, Adisa AO, Olajolo OA. Directly observed short
course therapy for tuberculosis--a preliminary report of a three-year experience
in a teaching hospital. J Natl Med Assoc. 2003 Nov;95(11):1082-8.
9215.
Lee HN, Embi CS, Vigeland KM, White CR Jr. Concomitant pulmonary
tuberculosis and leprosy. J Am Acad Dermatol. 2003 Oct;49(4):755-7.
Therapy:
9216. Ustianowski AP, Lockwood DN. Leprosy: current diagnostic and treatment approaches. Curr Opin Infect Dis. 2003 Oct;16(5):421-7. Review.
JULY, 2004
Diagnosis,
Diagnostics, Immunodiagnosis & Immunodiagnostics:
9913.
Dugue C, Perraut R, Youinou P, Renaudineau Y. Effects of anti-endothelial
cell antibodies in leprosy and malaria. Infect Immun. 2004 Jan;72(1):301-9.
9914.
Ebenezer
GJ, Daniel E. Expression of protein gene product 9.5 in lepromatous eyes showing
ciliary body nerve damage and a "dying back" phenomenon in the
posterior ciliary nerves. Br J Ophthalmol. 2004 Feb;88(2):178-81.
9915.
Geluk A,
van Meijgaarden KE, Franken KL, Wieles B, Arend SM, Faber WR, Naafs B, Ottenhoff
TH. Immunological crossreactivity of the Mycobacterium leprae CFP-10 with its
homologue in Mycobacterium tuberculosis. Scand J Immunol. 2004 Jan;59(1):66-70.
9916.
Imaz MS, Comini MA, Zerbini E, Sequeira MD, Latini O, Claus JD, Singh M.
Evaluation of commercial enzyme-linked immunosorbent assay kits for detection of
tuberculosis in Argentinean population. J Clin Microbiol. 2004 Feb;42(2):884-7
9917.
Ravindran R, Anam K, Bairagi BC, Saha B, Pramanik N, Guha SK, Goswami RP,
Banerjee D, Ali N. Characterization of immunoglobulin G and its subclass
response to Indian kala-azar infection before and after chemotherapy. Infect
Immun. 2004 Feb;72(2):863-70.
9918.
Sinha
S, Mahadevan A, Lokesh L, Ashraf V, Chandrasekhar Sagar BK, Taly AB, Shankar SK.
Tangier disease--a diagnostic challenge in countries endemic for leprosy. J
Neurol Neurosurg Psychiatry. 2004 Feb;75(2):301-4.
Pathogenesis
9919.
de la Barrera S, Finiasz M, Fink S, Ilarregui J, Aleman M, Olivares L,
Franco MC, Pizzariello G, del Carmen Sasiain M. NK cells modulate the cytotoxic
activity generated by Mycobacterium leprae-hsp65 in leprosy patients: role of
IL-18 and IL-13. Clin Exp Immunol. 2004 Jan;135(1):105-13.
9920.
Hunger RE, Sieling PA, Ochoa MT, Sugaya M, Burdick AE, Rea TH, Brennan PJ,
Belisle JT, Blauvelt A, Porcelli SA, Modlin RL. Langerhans cells utilize CD1a
and langerin to efficiently present nonpeptide antigens to T cells. J Clin
Invest. 2004 Mar;113(5):701-8.
9921.
Matsuoka M, Zhang L, Budiawan T, Saeki K, Izumi S. Genotyping of
Mycobacterium leprae on the basis of the polymorphism of TTC repeats for
analysis of leprosy transmission. J Clin Microbiol. 2004 Feb;42(2):741-5.
9922.
Prevot G, Bourreau E, Pascalis H, Pradinaud R, Tanghe A, Huygen K,
Launois P.
Differential production of systemic and intralesional gamma interferon
and interleukin-10 in nodular and ulcerative forms of Buruli disease. Infect
Immun. 2004 Feb;72(2):958-65.
Vaccines
9923.
Al-Attiyah
R, Mustafa AS.
Computer-assisted prediction of HLA-DR binding and experimental analysis
for human promiscuous Th1-cell peptides in the 24 kDa secreted lipoprotein (LppX)
of Mycobacterium tuberculosis. Scand J Immunol. 2004 Jan;59(1):16-24.
Therapy
9924.
Crawford CL. Licensing thalidomide in Australia. Med J Aust. 2004 Feb
16;180(4):199-200; discussion 200.
9925.
Laffitte E, Revuz J. Thalidomide: an old drug with new clinical
applications. Expert Opin Drug Saf. 2004 Jan;3(1):47-56. Review.
9926.
Staples J. Delineating disease: self-management of leprosy identities in
South India. Med Anthropol. 2004 Jan-Mar;23(1):69-88.
9927.
Villahermosa LG, Fajardo TT Jr, Abalos RM, Cellona RV, Balagon MV, Dela
Cruz EC, Tan EV, Walsh GP, Walsh DS. Parallel assessment of 24 monthly doses of
rifampin, ofloxacin, and minocycline versus two years of World Health
Organization multi-drug therapy for multi-bacillary leprosy. Am J Trop Med Hyg.
2004 Feb;70(2):197-200.
OCTOBER, 2004
Diagnosis,
Diagnostics, Immunodiagnosis & Immunodiagnostics:
10548.
Spencer JS, Kim HJ, Marques AM, Gonzalez-Juarerro M, Lima MC, Vissa VD,
Truman RW, Gennaro ML, Cho SN, Cole ST, Brennan PJ. Comparative analysis of B-
and T-cell epitopes of Mycobacterium leprae and Mycobacterium tuberculosis
culture filtrate protein 10. Infect Immun. 2004 Jun;72(6):3161-70.
10549.
Britton WJ, Lockwood DN. Leprosy. Lancet. 2004 Apr 10;363(9416):1209-19.
Review.
Pathogenesis:
10550.
Nepal BP, Shrestha UD. Ocular findings in leprosy patients in Nepal in
the era of multidrug therapy. Am J Ophthalmol. 2004 May;137(5):888-92.
10551.
Sunderkotter CH, Tomimori-Yamashita J, Nix V, Maeda SM, Sindrilaru A,
Mariano M, Sorg C, Roth J. High expression of myeloid-related proteins 8 and 14
characterizes an inflammatorily active but ineffective response of macrophages
during leprosy. Immunology. 2004 Apr;111(4):472-80.
Therapy:
10552.
Crawford CL. Does
thalidomide have a role in leprosy? Lancet. 2004 Jun 5;363(9424):1911.